Neonatal polycythemia and hyperviscosity occur with in-. perinatal complication in infants of diabetic mothers creased frequency in infants who are small for gestational age, in (IDM). To investigate the regulation of erythropoiesis in pregnancies complicated by maternal preeclampsia or prolonged, these infants, we measured cord blood erythropoietin (EP) gestation, and in IDM (1). Intrauterine hypoxemia has been. levels by a sensitive radioimmune assay and examined the proposed as the common underlying metabolic stimulus for growth of erythroid progenitor colonies in a series of I D M increased erythropoiesis in these pregnancies. Studies in gravid1 and control infants. Fifteen of 18 diabetic mothers were sheep by Zanjani and associates (2-4) have demonstrated that managed on a protocol emphasizing careful glycemic con-fetal erytliropoiesis is regulated by endogenously produced EF' trol throughout pregnancy; 10 had glycosolated hemoglobin and is responsive to a variety of hormonal stimuli. Elevated values within the normal, nondiabetic range during the umbilical cord blood EP levels have been reported in human third trimester. Cord blood E P was elevated in one of 18 pregnancies complicated by erythroblastosis fetalis or preeclamp-I D M and in two of 13 controls (p = NS). In IDM, cord sia (5).
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blood E P values were higher in infants delivered following
Studies in a number of animal models have shown that the maternal labor and were inversely correlated with umbilical metabolic abnormalities present in diabetic pregnancies are as.. artery pH ( r = -0 . 7 2 ;~ = 0.006). Growth of burst forming sociated with a significant reduction in arterial oxygen context units-erythroid was similar in I D M and controls in the and with a reciprocal increase in plasma EP, suggesting a mech.. presence of 0.1 to 2.0 U of exogenous EP per ml of anism for polycythemia in IDM (6) (7) (8) (9) . High cord blood EP level:; methylcellulose medium. Individual infants tended to re-are present in IDM delivered after intrauterine fetal demise (5) , spond consistently over the entire range of E P doses tested. and autopsies of liveborn infants who die during the first 48 h of The number of burst forming units-erythroid observed did life have shown a marked increase in hepatic hematopoietic not correlate with cord blood EP, birth weight, or neonatal tissue (10). Widness and co-workers found elevated umbilical hematocrits. We conclude that: (a) umbilical cord blood cord blood EP levels in 36% of 6 1 IDM (7). In their series, EF' E P levels are generally normal in I D M delivered by moth-values correlated with plasma insulin levels, but not with either ers in whom good glycemic control is maintained through-central venous hematocrit or reticulocyte counts (7) . out gestation, (b) cord blood E P values are strongly inflnAnalysis of the postulated interrelationship of intrauterine enced by perinatal events, and (c) the response of erythroid hypoxemia, elevated EP, and polycythemia in IDM is compliprogenitors to E P is intrinsically normal in IDM. These cated by a number of factors. Because EP is released acutely in data suggest that polycythemia is an adaptive response in response to perinatal stress (1 1, 12), cord blood values may not I D M and is not associated with a primary abnormality in accurately reflect intrauterine conditions. In addition, erythroerythropoiesis. In *addition, because perinatal stress ap-poiesis is qualitatively abnormal in IDM (13, 14) and may be pears to acutely increase cord blood EP, elevated levels in ineffective (1 5). Up regulation of insulin receptors on circulatin;; cord blood may not accurately reflect baseline E P release blood cells is observed in diabetic adults and IDM (16, 17) ; the in utero. (Pediatr Res 20: 161-165, 1986) effect of this abnormality on erythropoiesis is unknown. Over the past decade, in vitro culture systems for erythroid Abbreviations progenitor cells have facilitated laboratory investigation of normal and abnormal erythropoiesis. Colonies derived from earl:y EP, erythropoietin progenitors, termed BFU-E, can be enumerated from human IDM, infants of diabetic mothers umbilical cord blood (18) . Availability of a controlled system in BFU-E, burst forming units-erythroid which progenitors can be induced to undergo clonal proliferation FBG, fasting blood glucose and differentiation allowed us to address a number of questions PPBG, postprandial blood glucose about IDM. We assessed the effectiveness of erythropoiesis at the progenitor level by stimulating burst formation in IDM and controls over a range of EP doses. This approach has been utilized The experimental design thus allowed us to test the following specific hypotheses related to polycythemia in IDM: (a) that erythropoiesis at the progenitor cell level is normal in IDM and that neonatal polycythemia results from an adaptive response to the intrauterine environment, (b) that a relationship might exist between neonatal hematocrits and the number of BFU-E in cord blood and, (c) that a program emphasizing careful glycemic control of maternal diabetes would result in normal cord blood EP values and in a low incidence of polycythemia in their infants.
METHODS
Patient population. Study mothers included 15 insulin-dependent diabetic women who were enrolled in a program of emphasizing careful glycemic control during gestation and supervised by one of the authors (JLK). These women, subgrouped according to White's modified classification (20) , included six class B women, six class C, and three class D. Three class A diabetic mothers not managed on this protocol were also studied. Control subjects were healthy, nondiabetic mothers admitted for delivery. All control mothers received a 50-g glucola challenge at 28 wk gestation: serum glucose values 1 h after glucola were normal in all.
Control infants and IDM had Apgar scores assigned at one and five minutes of age. Two IDM (one each in classes A and C) and one control infant had a 1-minute Apgar score <7; all infants had Apgar scores of at least 7 at 5 min. Gestational age was determined on the basis on maternal dates, confirmed by ultrasound in diabetic women, and later correlated with newborn physical examination. The mean gestational age of control infants was 38.6 t-1.7 and 38.1 f 1.3 wk for IDM. The direct Coombs' test was negative in all cord blood specimens. A birth weight index was calculated for all infants by dividing the observed weight by the weight which corresponded to the 50th percentile for that gestational age and sex (2 1). Macrosomia was defined as a birth weight index of B1.25. All mothers enrolled in the study gave informed consent for sampling of umbilical cord blood.
Management ofmaternal diabetes.
All subjects self-monitored capillary blood glucose values with reflectance colorimeters. Testing was carried out at least four times per day, before breakfast and after meals. Six subjects began intensive treatment prior to conception, six in the 1 st trimester, two in the 2nd trimester, and one woman was initially diagnosed when she presented in diabetic ketoacidosis at 31 wk gestation. A daily diet consisting of 25-35 kcallkg of ideal body weight (adjusted for pattern of weight gain) was prescribed. Caloric intake was given as 40-50% carbohydrate, 75-100 g of protein; natural fiber was encouraged and the diet was divided as three meals and three snacks. Five subjects were managed by use of continuous insulin-infusion pump therapy, and 10 used a mixture of regular and intermediate insulin divided as two (four women), three (five women), or four (one woman) injections per day. Patients were taught that the goal of the diet-insulin-physical activity regimen was to maintain the FBG between 60-100 mg/dl and the PPBG between 110-150 mg/dl.
The results of diabetes management were assessed by analysis of mean weekly FBG and PPBG values, measurement of monthly maternal glycosolated hemoglobin levels, and of umbilical cord blood glycosolated hemoglobin at delivery. Women were categorized as being in good control if mean FBG was < 100 mg/dl, moderate control if 100-149 mg/dl, and poor if r 150 mg/dl; and in good control if mean PPBG was <I50 mg/dl, moderate control 150-199 mg/dl, and poor control if 2200 mg/dl.
Laboratory studies. Whole blood, a mixture of arterial and venous blood, was collected from the cut end of the umbilical cord. A small quantity was allowed to clot at room temperature and was refrigerated at 4" C for up to 24 h before separation of serum. Sera were stored at -70" C before analysis. Erythropoietin was measured by a sensitive radioimmune assay which has been described (1 1, 22 ).
An additional 5-10 ml of cord blood was collected into 10 ml of heparinized culture medium. These samples were kept at room temperature from 1-24 h prior to separation of mononuclear cells by Ficoll-Hypaque flotation. Washed mononuclear cells were resuspended at 6 x lo5 cells per ml in Iscove's Modified Dulbecco's Medium for plating in culture medium consisting of 0.8% methylcellulose supplemented with 30% fetal calf serum (Flow Laboratories, MacLean, VA; lot 29 10 1036), 1.2% bovine serum albumen, transfemn, L-glutamine, and a final concentration of M 2-mercaptoethanol. Commercial colony stimulating factor (GCT Medium, GIBCO, Grand Island, NY; lot 18K6242) was added to all cultures. Human urinary EP was obtained from the British Columbia Cancer Centre, Vancouver, B.C. The dose-response characteristics of IDM and control mononuclear cells were assessed at EP concentrations between 0.1 and 2.0 U/ml to evaluate the overall number of circulating progenitors and their sensitivity to EP. Duplicate 35 mm plates (Falcon, Oxnard, CA) containing 1 ml of methylcellulose medium and a final concentration of 5 x lo4 cells per plate were cultured. Colonies derived from BFU-E were enumerated on day 14 by indirect light microscopy using the criteria of Gregory and Eaves (23) . Colonies were only scored as derived from BFU-E if they appeared red. In addition, BFU-E were categorized into "early" and "late" maturing subclasses on the basis of the number of discrete clusters identified in individual colonies (23) .
Capillary hematocrits were measured by heel puncture within 4 h of birth in all infants. In addition, automated venous complete blood counts were performed at 4 h of age in all infants delivered at the Naval Hospital on a Coulter Model S+ instrument. Paired capillary and venous hematocrit values were available in 70% of the infants studied and were closely correlated ( r = 0.9 1; p < 0.00 1). Specimens collected from the umbilical artery at delivery were submitted for blood gas measurement in 13 IDM. Glycosolated hemoglobin determinations were camed out by the thiobarbituric acid technique as previously described (24) .
Paired cord blood specimens for growth of BFU-E and measurement of EP were available on 17 of 18 IDM and on 13 of 17 controls. Sera were not obtained for EP in 5 normal infants and in 1 IDM who had erythroid colony cultures performed.
Statistical analysis. Student's unpaired t test was employed for all statistical analysis, except as noted in the text. Because of the nonparametric distribution of data within the IDM group, comparisons between IDM delivered with and without prior maternal labor were made by applying the Mann-Whitney U test. All means are reported f 1 SD unless otherwise noted.
RESULTS

Control of maternal diabetes and neonatal findings. All 15
insulin-dependent diabetic mothers in whom glycemic control was carefully monitored delivered liveborn infants between 37 and 39 wk gestation. In these patients, the mean maternal FBG was 1 10 + 17 mg/dl, and mean PPBG was 145 k 10 mg/dl for 20-39 wk. The distribution of mean FBG and PPBG values in the 15 diabetic subjects at different stages of gestation is given in Table 1 . By the last 7-9 wk of gestation, control of FBG was good in four women and moderate in the other eleven. Better control of PPBG was achieved, with 13 women classified as in good control and two in moderate control by the end of pregnancy. For the entire group, mean glycosolated hemoglobin for 20-39 wk gestation was 7.4 + 1.2%. By the end of pregnancy, maternal glycosolated hemoglobin values were in the normal, nondiabetic range (<7.6% of total hemoglobin) in 10 subjects, and were elevated by 0.1-1.2% of total hemoglobin in five. Six of the 15 insulin-dependent mothers delivered macrosomic neo- Fig. 1 . Correlation of umbilical artery pH and log cord blood EP in he 13 IDM in whom both were measured. The observed logarithmic -elationship is consistent with previous data on the EP response in normal iubjects (30).
lates, including one of five women with elevated glycosolated ~emoglobin values at the end of gestation and five of 10 in whom he glycosolated hemoglobin was normal. Two of the three nothers with gestational diabetes delivered infants with macro-;omia. Overall, seven of 18 IDM and two of 17 control infants Nere macrosomic.
The mean cord blood glycosolated hemoglobin was 4.4 f 0.3% ~f total hemoglobin (absorbance 0.135 + 0.009) in the infants of nsulin-dependent diabetic mothers and 3.6 + 0.2% (absorbance (Fig. 1) . A similar inverse correlation was observed between cord blood EP and base deficits calculated from umbilical artery blood gases ( r = -0.75; p < 0.005).
Umbilical cord pH was not measured routinely on controls. When IDM were stratified according to the presence or absence of maternal labor prior to delivery, infants who were born following labor were noted to have significantly lower umbilical artery pH and higher cord blood EP values than babies whose mothers were delivered operatively without labor (mean pH:
7.19 versus 7.30; p < 0.025 by Mann-Whitney U; mean EP: 90.7 versus 23.3; p < 0.005 by Mann-Whitney U). Because only two control mothers underwent elective caesarian deliveries, meaningful analysis of EP levels in the presence and absence of labor could not be performed in control infants.
Erythroid colony growth. In cultures canied out in the absence of exogenous EP, less than I BFU-E derived colony was observed per lo5 cells plated in both IDM and controls. The range of total BFU-E colonies was similar in both groups at concentrations of EP from 0.1 to 2.0 U/ml of methylcellulose (Table 2 ). In addition, the growth of late-maturing, highly proliferative BFU-E were equivalent in both groups. This subclass of BFU-E is thought to derive from an early progenitor cell and requires higher doses of EP for maximal development in vitro (23) . Although the number of BFU-E colonies present in cultures varied widely among infants, the response of each patient tended to be consistent over the range of EP doses studied. For individual patients, total BFU-E observed at the lowest dose of exogenous. EP (0.1 U/ml) correlated well with growth at 2 U/ml, the highest dose tested ( r = 0.846; p < 0.0001 for control infants and r = 0.919; p < 0.0001 for IDM) (Fig. 2) . There was no significant relationship observed between the growth of BFU-E and capillary hematocrit, birth weight index or serum EP levels in either controls or in IDM.
DISCUSSION
Previous studies of the pathogenesis of polycythemia in IDM have focused on the effects of metabolic abnormalities present during diabetic pregnancies on oxygen transport and EP produc-. tion. The influence of fetal hyperglycemia and hyperinsulinemia. on erythropoietin release and erythropoiesis has been investi-. gated in human pregnancies and in a number of animal species. Fetal hyperglycemia leads to decreased blood oxygen content and elevated EP values in fetal sheep (8, 9) . Experimentally induced fetal hyperinsulinemia also is associated with impaired oxygenation (6) , and a relationship between cord blood hyper-. insulinemia and increased EP was reported by Widness et al. (7) . The observation that reduction in arterial p 0 2 and oxygen satu-. ration correlate with increased glycosolated hemoglobin levels during gestation in diabetic women provides further evidence: that chronic hyperglycemia decreases oxygen availability (25) . The capacity of the human fetus to respond to chronic intrauter-. ine hypoxemia by releasing EP is suggested by reports showing: Fig. 2 . Relationship of BFU-E growth at the lowest (0.1 U/ml) and highest (2.0 U/ml) EP test concentrations. There was an approximate three-fold increase in total BFU-E in both IDM (0) and control (A) subjects observed between 0.1 and 2.0 U/ml. For all patients, the number of colonies present at 0. I U/ml of EP was highly predictive of growth in plates receiving 2.0 U/ml (11 < 0.0001). Data were not available for two IDM and two control infants at 0.1 U/ml of EP. All four had normal hematocrits and normal growth at 2 U/ml of EP.
elevated cord blood EP levels in pregnancies complicated by erythroblastosis fctalis, preeclampsia, and maternal diabetes (5, 7) . and the acute stress of normal labor has been associated with increased cord blood EP (1 1, 12). The increased incidence of polycythemia in infants born at high altitudes (26) provides additional evidence implicating hypoxemia in its pathogenesis.
The converging evidence that hyperglycemia and hyperinsulinemia reduce blood oxygen content and stimulate the production of fetal EP suggests a mechanism for polycythemia in IDM. However, a number of issues have not been resolved. Widness rt a/. (7) reported that over one-third of IDM had elevated EP levels in cord blood; however, EP levels did not correlate with neonatal hematocrit values. A recent study of 10 IDM (five with polycythemia) did not reveal any with elevated EP in cord blood (13) . In addition, EP levels were not correlated with neonatal hematocrits in the IDM we examined. This lack of association between cord blood EP values and polycythemia may be explained in part by the kinetics of the erythroid response to EP. Serum EP values fall dramatically in patients with sickle cell anemia a few hours after beginning supplemental oxygen therapy and rise measurably within 3 hours of its discontinuation (27) . Changes in reticulocyte counts do not occur until 2-3 days later (27) . Meberg (28) produced hypoxemia in fetal rats by exposing their mothers to low concentrations of inspired oxygen for periods between 6 h and 8 days. Elevated plasma EP values were noted by 6 h in fetal rats; however, after 8 days of hypoxemia plasma EP was normal in both infants and mothers while hematocrits were increased. Taken together with our finding that umbilical cord EP and pH were inversely related, these experimental results suggest that neonatal polycythemia is an endproduct of chronic intrauterine hypoxemia while cord blood EP values are strongly influenced by intrapartum stress.
An alternative explanation for the observation that cord blood EP values do not correlate with hematocrits in IDM is that the erythroid response to EP is blunted. Stevenson et al. (15) found increased pulmonary excretion of carbon monoxide in IDM and suggested that this might reflect ineffective erythropoiesis. Recent reports that the switch from fetal to adult hemoglobin synthesis is delayed in IDM provides additional evidence that erythropoiesis is qualitatively abnormal in these infants (23) . We tested the hypothesis that polycythemia in IDM is a secondary response to conditions in the fetal environment, rather that the result of a primary abnormality of hematopoietic cells by examining the growth of erythroid progenitors in vitro. We observed that the total number of BRI-E cultured and the dose-response curve over a range of exogenous EP doses were comparable in IDM and controls. These data suggest intrinsically normal erythroid proliferation in IDM and support the hypothesis that polycythemia in these infants is a secondary phenomenon, rather than the result of a primary hematopoietic abnormality. Although a wide range of BFU-E growth was observed in both IDM and controls, individual patients showed a consistent pattern of response in the presence of varying amounts of EP. The finding that subjects tended to be either high, low, or normal responders over the entire range of exogenous EP studied supports differences in the actual number of erythroid progenitors present, rather than variable sensitivity of progenitors to EP. Factors that regulate the number of colony-forming cells in the fetal circulation have not been determined; however, we observed no correlation of gestational age, maternal diabetes, or capillary hematocrit with the growth of BFU-E derived colonies. Only a few infants in our series had hematocrits in excess of 65% and it is possible that a relationship between neonatal hematocrits, EP values, and burst formation might have been apparent if more polycythemic newborns had been available for study.
The low frequency of elevated cord blood EP values we observed contrasts with the data of Widness and associates (7) who found increased cord blood EP in 22 of 61 IDM. Serum EP values were determined by an identical method in the same reference laboratory and the infants enrolled in both studies were nonasphyxiated by the criteria of Apgar scores. A potentially important difference is that good biochemical control of maternal diabetes was emphasized in the mothers we studied. Careful management of maternal glucose metabolism during gestation perhaps minimized the amount of chronic hypoxic stress due to hyperglycemia and/or hyperinsulinemia in our patients. The low incidence of polycythemia in our patients might have resulted from the elimination of a major intrauterine stimulus for EP release. However, it is important to emphasize that normoglycemia was not achieved in the IDM we studied as cord blood glycosolated hemoglobin values were higher and macrosomia was more frequent than in controls.
Our data emphasize the influence of intrapartum stress on cord blood EP values and suggest that a complex set of factors contribute to EP levels in IDM. We believe that the release of EP in utero is important in the pathogenesis of neonatal polycythemia, but our results suggest that cord blood EP values may not accurately reflect fetal erythropoiesis. Amniotic fluid EP has recently been shown to be increased in IDM and in infants delivered by hypertensive mothers and does not appear to be influenced as much by the events of labor as cord blood EP (29) .
A prospective study that controls for the influence of labor and other acute perinatal factors on cord blood EP or which examines amniotic fluid EP will be required to directly address the effects of intrauterine hyperglycemia on fetal EP production. If careful glycemic control during gestation reduces the degree of fetal hypoxemia, the incidence of perinatal complications may decrease. A sensitive and widely available method of measuring fetal EP in high-risk pregnancies may permit the early identification of some infants who are experiencing significant intrauterine hypoxemia.
